Inactive Instrument
MediXall Group, Inc. Stock Other OTC
Stocks
MDXL
US58504K1043
Healthcare Facilities & Services
OTC Markets Traded| Market Cap | 777K 668K 629K 574K 1.07M 73.39M 1.08M 7.44M 2.88M 37.63M 2.92M 2.85M 120M | P/E 2022 |
-10.5x | P/E 2023 | - |
|---|---|---|---|---|---|
| Enterprise Value | 4.6M 3.95M 3.72M 3.39M 6.35M 434M 6.37M 44.04M 17.03M 223M 17.26M 16.88M 709M | EV / Sales 2022 |
1,357x | EV / Sales 2023 | 12.3x |
| Free-Float |
91.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Travis Jackson
CEO | Chief Executive Officer | - | 2022-08-29 |
Shane Glavin
DFI | Director of Finance/CFO | - | 2023-12-05 |
Ann Hawkins
CTO | Chief Tech/Sci/R&D Officer | 72 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Hood
BRD | Director/Board Member | 77 | 2023-10-09 |
Scott Powell
BRD | Director/Board Member | 73 | 2023-12-05 |
Shane Glavin
BRD | Director/Board Member | - | 2023-12-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -2.73% | - | - | 735K | ||
| -0.40% | -3.92% | -42.76% | +301.01% | 6.47B | ||
| +2.15% | -3.88% | -6.22% | - | 1.39B | ||
| -2.94% | -3.38% | -19.69% | -72.66% | 1.14B | ||
| -1.96% | +8.89% | +86.10% | -53.61% | 221M | ||
| Average | -0.63% | -0.57% | +4.36% | +58.25% | 2.31B | |
| Weighted average by Cap. | -0.37% | -3.54% | -31.29% | +236.53% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 59.27K 50.99K 47.97K 43.77K 81.87K 5.6M 82.11K 568K 220K 2.87M 223K 218K 9.14M | 309K 266K 250K 229K 427K 29.23M 429K 2.96M 1.15M 14.99M 1.16M 1.14M 47.73M |
| Net income | -6.83M -5.88M -5.53M -5.04M -9.44M -645M -9.46M -65.44M -25.3M -331M -25.65M -25.09M -1.05B | -4.56M -3.93M -3.69M -3.37M -6.3M -431M -6.32M -43.72M -16.91M -221M -17.14M -16.76M -704M |
| Net Debt | 2.82M 2.42M 2.28M 2.08M 3.89M 266M 3.9M 26.99M 10.44M 136M 10.58M 10.35M 435M | 3.82M 3.29M 3.09M 2.82M 5.28M 361M 5.29M 36.6M 14.15M 185M 14.34M 14.03M 589M |
Employees
-
















